If you’ve ever wondered what to do with Stryker stock, you’re definitely not alone. This medical devices giant has long been ...

Netflix lifts its cash flow outlook, Mastercard expands via acquisitions, and Citigroup gains on strong NII and ...

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $424.33, accompanied by a ...

Biocomposites has launched its SYNICEM range of spacers for hip, knee, and shoulder revision surgery in the US.

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Named NGC2-ready Expeditionary X-domain Undetectable Stryker (NEXUS), the vehicle has reduced signatures across the visual, ...

J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

The Flinn Foundation recently released the latest version of its Bioscience Roadmap for Arizona — a guide to the sector in ...

What do Irish EV owners really think of life behind the electric wheel? We’ve gathered together some experienced EV drivers, who’ve had their cars on the road for at least a few years, or who are ...

Armored personnel carriers (APCs) aren’t just for military use—they’re also marvels of engineering and design. This article ...

Cardinal Health, Inc. CAH is scheduled to report first-quarter fiscal 2026 results on Oct. 30, before market open. In the ...